Speranza Therapeutics

Speranza Therapeutics distributes and clinically supports orphan drugs and medical devices, creating options for patients whose chronic illnesses are not being effectively addressed. Our guiding principle is simple - To remove the inherent challenges in delivering treatment to patients in need through proven, clinically effective therapeutics and technology. S.T. GenesisTM is the first Speranza Therapeutics Innovation to hit the market. S.T. Genesis is an FDA-cleared Percutaneous Nerve Field Stimulator (PNFS), used as an aid to reduce the symptoms of opioid withdrawal. This powerful solution to the opioid crisis will partner with treatment centers, providing them with leading clinical technology, comprehensive...

Medical devices,innovative drugs,and clinical support

Speranza therapeutics operates in the Biotechnology research industry.

Speranza therapeutics's revenue is 11m - 100m

Speranza therapeutics has 11 - 50 employees.